International dosage differences in fluoxetine clinical trials.

International dosage differences in fluoxetine clinical trials.

OBJECTIVE: International differences are thought to exist in dosages used by clinicians treating mood disorders. This study examined international dosage differences in antidepressant clinical trials, using a database formed and maintained as a component of a Cochrane review of comparative clinical...

Bibliografski detalji
Glavni autori:	Patten, S, Cipriani, A, Brambilla, P, Nosè, M, Barbui, C
Format:	Journal article
Jezik:	English
Izdano:	2005

Slični predmeti

Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.
od: Brambilla, P, i dr.
Izdano: (2005)

Are all antidepressants really the same? The case of fluoxetine: a systematic review.
od: Cipriani, A, i dr.
Izdano: (2006)

Fluoxetine versus other types of pharmacotherapy for depression.
od: Cipriani, A, i dr.
Izdano: (2005)

Fluoxetine versus other types of pharmacotherapy for depression
od: Cipriani, A, i dr.
Izdano: (2009)

Fluoxetine and amitriptyline: First-line treatments or reference compounds?
od: Barbui, C, i dr.
Izdano: (2004)

Allocation concealment and blinding in clinical trials.
od: Cipriani, A, i dr.
Izdano: (2008)

Fluoxetine versus other types of pharmacotherapy for depression
od: Magni, L, i dr.
Izdano: (2013)

"Wish bias" in antidepressant drug trials?
od: Barbui, C, i dr.
Izdano: (2004)

Efficacy and tolerability of pharmacological treatments for personality disorders: A meta-analysis
od: Nose, M, i dr.
Izdano: (2005)

What is a risk ratio?
od: Cipriani, A, i dr.
Izdano: (2007)

Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
od: Nosè, M, i dr.
Izdano: (2006)

Outcome reporting bias in clinical trials.
od: Esposito, E, i dr.
Izdano: (2009)

Why internal and external validity of experimental studies are relevant for clinical practice?
od: Cipriani, A, i dr.
Izdano: (2009)

EMA must improve the quality of its clinical trial reports.
od: Barbui, C, i dr.
Izdano: (2011)

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
od: Cipriani, A, i dr.
Izdano: (2013)

Cluster randomised trials.
od: Barbui, C, i dr.
Izdano: (2011)

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
od: Barbui, C, i dr.
Izdano: (2011)

What is a factorial trial?
od: Cipriani, A, i dr.
Izdano: (2013)

Simple spectrophotometric methods for determination of fluoxetine and clomipramine hydrochlorides in dosage forms and in some post-mortem biological fluids samples
od: Emam A. Ali, i dr.
Izdano: (2016-12-01)

Explanatory and pragmatic trials.
od: Barbui, C, i dr.
Izdano: (2007)

Assessing risk of bias in randomized controlled trials.
od: Purgato, M, i dr.
Izdano: (2010)

Imputing response rates from means and standard deviations in meta-analyses.
od: Furukawa, T, i dr.
Izdano: (2005)

Imputing missing standard deviations in meta-analyses can provide accurate results.
od: Furukawa, T, i dr.
Izdano: (2006)

An open-label trial of risperidone and fluoxetine in children with autistic disorder
od: Desousa Avinash
Izdano: (2010-01-01)

Randomized trials published in Chinese or Western journals: comparative empirical analysis.
od: Purgato, M, i dr.
Izdano: (2012)

Fluoxetine in Tourette Syndrome
od: J Gordon Millichap
Izdano: (1991-07-01)

Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy.
od: Power, A, i dr.
Izdano: (1992)

Ecofriendly and smart spectrophotometric approaches for synchronized analysis of two antipsychotic drugs, fluoxetine and olanzapine: application to combined tablet dosages with assessment of method greenness
od: Sayed M Derayea, i dr.
Izdano: (2025-02-01)

[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence].
od: Purgato, M, i dr.
Izdano: (2012)

Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach.
od: Veronese, A, i dr.
Izdano: (2008)

Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine
od: Elizabeth A. Pekarskaya, i dr.
Izdano: (2021-11-01)

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
od: Hashemi SN, i dr.
Izdano: (2012-01-01)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
od: Cipriani, A, i dr.
Izdano: (2009)

Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
od: Mehran Zarghami, i dr.
Izdano: (2018-06-01)

Fluoxetine improves minor depressive disorders.
od: Cowen, P
Izdano: (2005)

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.
od: Barbui, C, i dr.
Izdano: (2008)

Serum sodium changes in fluoxetine users at different age groups.
od: Fereshteh Shakibaei, i dr.
Izdano: (2010-09-01)

Serum Sodium Changes in Fluoxetine Users at Different Age Groups
od: Khalil Talaeizadeh, i dr.
Izdano: (2010-08-01)

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
od: Zou C, i dr.
Izdano: (2013-11-01)

The Possible Role of Fluoxetine in Adenomyosis: An Animal Experiment with Clinical Correlations
od: Parama Sengupta, i dr.
Izdano: (2013-07-01)